Gene study aims to unlock mysteries of deadly heart shock
NCT ID NCT05728359
First seen Nov 18, 2025 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study collects blood samples from 300 people with cardiogenic shock (a severe heart condition) to analyze their genes and immune markers. The goal is to find patterns that explain why some patients respond differently to treatment. No new treatment is given; this is purely observational research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barts Health NHS trust
RECRUITINGLondon, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.